TherapeuticsMD TXMD
NASDAQ TXMD
$1.85 -0.05 (-2.63%)
At close: Oct 22, 2026 · 4:00 PM EDT

TherapeuticsMD (TXMD) Long-Term Debt Issuances (2011 - 2013)

Updated

TherapeuticsMD's Long-Term Debt Issuances came in at $75 million for FY2018.

Analysis

TherapeuticsMD (TXMD) Long-Term Debt Issuances (2011 - 2013) Analysis & Trends

  • The FY2018 figure represents the lowest annual Long-Term Debt Issuances since FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 TherapeuticsMD 21.59 Mn 21.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 400,000.00
Dec 31, 2011 148,404.00
Sep 30, 2011 1,512.00
API Access

TherapeuticsMD Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TXMD&period=max&api_key=YOUR_API_KEY